Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Arterial Thrombosis
- COVID-19
- Venous Thromboembolism
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Factorial AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04409834
- Collaborators
- Not Provided
- Investigators
- Study Chair: Marc S Sabatine, MD, MPH TIMI Study Group Principal Investigator: David A Morrow, MD, MPH TIMI Study Group
Get Well Soon